Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aspirin and stroke prevention: how much?

G J Toffol1

  • 1College of Osteopathic Medicine of the Pacific, Pomona, Calif.

The Journal of the American Osteopathic Association
|May 1, 1990
PubMed
Summary

Aspirin at 1300 mg daily is recommended for stroke prevention after transient ischemic attack (TIA). This dosage is effective as a sole antiplatelet agent, clarifying existing confusion regarding optimal use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brachial plexopathy secondary to anticoagulant-induced hematoma as a complication of axillary arteriography.

The Journal of the American Osteopathic Association·1997
Same author

Focal atrophy and cerebrospinal fluid rhinorrhea.

The Journal of the American Osteopathic Association·1997
Same author

Adult Arnold-Chiari malformation: a postpartum case presentation.

The Journal of the American Osteopathic Association·1995
Same author

Confirmation of traumatic interhemispheric subdural hematoma by magnetic resonance imaging.

The Journal of emergency medicine·1994
Same author

Stroke in young adults. A continuing diagnostic challenge.

Postgraduate medicine·1992
Same author

Transient global amnesia.

Postgraduate medicine·1990

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Media focus on aspirin for heart attack prevention overshadows its role in stroke prevention.
  • Clinical data on aspirin for stroke prevention post-transient ischemic attack (TIA) exists but lacks clarity on optimal dosing and comparative effectiveness.
  • Confusion persists regarding appropriate antiplatelet agent selection and dosage for TIA patients.

Purpose of the Study:

  • To review the mechanism of action of aspirin in stroke prevention.
  • To provide clinical trial evidence supporting aspirin's efficacy for stroke prevention following TIA.
  • To recommend a specific daily dosage of aspirin as the primary oral antiplatelet therapy.

Main Methods:

  • Literature review of clinical trials and pharmacological data.
  • Analysis of aspirin's mechanism of action.
  • Evaluation of evidence for stroke prevention in TIA patients.

Main Results:

  • Aspirin's antiplatelet mechanism is detailed.
  • Clinical trials provide a rationale for specific dosing strategies.
  • Evidence supports aspirin's role in preventing recurrent stroke after TIA.

Conclusions:

  • A daily dose of 1300 mg of aspirin is recommended for stroke prevention in patients with TIA.
  • This dosage is proposed as the sole orally administered antiplatelet agent.
  • The review aims to resolve confusion surrounding aspirin's use in stroke prevention.

Related Experiment Videos